Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
Sponsor: Genascence Corporation
Summary
The goal of this clinical trial is to learn if GNSC-001 works to treat knee osteoarthritis in adults. It will also learn about the safety of GNSC-001. The main questions it aims to answer are: 1. Does GNSC-001 lower daily knee joint pain and improve function in participants? 2. What medical problems do participants have when taking GNSC-001? Researchers will compare GNSC-001 to a placebo (a look-alike substance that contains no drug) to see if GNSC-001 works to treat knee osteoarthritis. Participants will: 1. Receive a single injection of immune-modulation, and GNSC-001 or a placebo, in their knee 2. Take an oral immune-modulating pill every day for the first 22 days 3. Visit the clinic at least 9 times over 2 years for checkups and tests 4. Keep a diary of their symptoms and the number of times they use a rescue medication
Official title: A Randomized, Double-blind, Placebo-controlled, Phase 2/3, Study to Evaluate the Efficacy and Safety of an Intraarticular Injection of GNSC-001 in Participants With Osteoarthritis of the Knee
Key Details
Gender
All
Age Range
40 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
240
Start Date
2027-07
Completion Date
2030-10
Last Updated
2026-09-21
Healthy Volunteers
No
Conditions
Interventions
Gene Therapy GNSC-001
Single intra-articular injection into target knee
Placebo
Single intra-articular injection into target knee